Received Oct 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | Z006279 | — |
No reported side effects/ No additional AE/No PQC.; 39-year-old female patient vaccinated with ProQuad; HCP calling to report a TE for PROQUAD. Product was administered to a patient; This spontaneous report has been received from a health care professional, regarding a 39-year-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 06-Oct-2025, the patient was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD), Injection (lot number: Z006279, which was determined to be valid as vial formulation, with an expiration date on 15-Sep-2026) as prophylaxis (strength, dose, scheme, route and anatomical location of administration were reported). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (lot number and expiration date were unknown). Temperature excursion details were not provided. No additional adverse event was reported.
MERCK STERILE DILUENT